Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8+ responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera

Virology

Volumn 323, Issue 2, 2004, Pages 220-232

  Chikhlikar, Priya ^a   Barros De Arruda, Luciana ^a   Agrawal, Shikha ^a,c   Byrne, Barry ^b   Guggino, William ^a   August, J Thomas ^a   Marques Jr , Ernesto T A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c APPLIED BIOSYSTEMS   (United States)

Author keywords

AAV; antigen presenting cell; APC; CD4; CD8; DNA vaccine; HIV 1 Gag; Inverted terminal repeat; LAMP; lysosome associated membrane protein; major histocompatibility complex; MHC; MHC class II enriched compartment; MHC II; MIIC; rAAV; Rev responsive elements; RRE

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; GAG PROTEIN; IMMUNOGLOBULIN G1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MEMBRANE PROTEIN; NAKED DNA; PARVOVIRUS VECTOR; PLASMID DNA; PRIMER DNA; PROTEIN P55; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DEPENDOVIRUS; FEMALE; GENE PRODUCTS, GAG; GENETIC VECTORS; HUMANS; IMMUNIZATION SCHEDULE; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PLASMIDS; PROTEIN PRECURSORS; RECOMBINANT FUSION PROTEINS; TERMINAL REPEAT SEQUENCES; VACCINES, DNA;

ADENO-ASSOCIATED VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 2942532790     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.02.025     Document Type: Article

References (37)

1. Chen Z.Y., Yant S.R., He C.Y., Meuse L., Shen S., Kay M.A. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Molec. Ther. 3:2001;403-410
2. Chirmule N., Xiao W., Truneh A., Schnell M.A., Hughes J.V., Zoltick P., Wilson J.M. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J. Virol. 74:2000;24205
3. Chou C.Y., Horng L.S., Tsai H.J. Uniform GFP-expression in transgenic medaka (Oryzias latipes) at the F0 generation. Transgenic Res. 10:2001;303-315
4. Deml L., Bojak A., Steck S., Graf M., Wild J., Schirmbeck R., Wolf H., Wagner R. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 gag protein. J. Virol. 75:2001;10991-11001
5. Doe B., Selby M., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8578-8583
6. Duan D., Sharma P., Yang J., Yue Y., Dudus L., Zhang Y., Fisher K.J., Engelhardt J.F. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72:1998;8568-8577
7. Duan D., Yan Z., Yue Y., Engelhardt J.F. Structural analysis of adenoassociated virus transduction circular intermediates. Virology. 261:1999;8-14
8. Fu Y., Kan D., Evans S. Transient transgenesis in Xenopus laevis facilitated by AAV-ITRs. Methods Mol. Biol. 127:1999;167-173
9. Hsiao C.D., Hsieh F.J., Tsai H.J. Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adenoassociated virus in zebrafish. Dev. Dyn. 220:2001;323-336
10. Hu H., Huston G., Duso D., Lepak N., Roman E., Swain S.L. CD4(+) T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2:2001;705-710
11. Huang Y., Kong W.-P., Nabel G.J. Human immunodeficiency virus Type-1 specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J. Virol. 75:2001;4947-4951
12. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev., Immunol. 2:2002;251-262
13. Kessler P.D., Podsakoff G.M., Chen X., McQuiston S.A., Colosi P.C., Matelis L.A., Kurtzman G.J., Byrne B.J. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14082-14087
14. q13qter. Genomics. 10:1991;831-834
15. Kotsopoulou E., Kim V.N., Kingsman A.J., Kingsman S.M., Mitrophanous K.A. A rev-independent Human Immunodeficiency Virus Type, 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74:2000;4839-4852
16. Maldarelli F., Martin M.A., Strebel K., Conover J., Gu M., Rosenberg A.S. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:1991;5732-5743
17. Manning W.C., Paliard X., Zhou S., Pat Bland M., Lee A.Y., Hong K., Walker C.M., Escobedo J.A., Dwarki V. Genetic immunization with adenoassociated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J. Virol. 71:1997;7960-7962
18. Marques E.T. Jr., Weiss J.B., Strand M. Molecular characterization of a fucosyltransferase encoded by Schistosoma mansoni. Mol. Biochem. Parasitol. 93:1998;237-250
19. Marques E.T. Jr., Chikhlikar P., De Arruda L.B., Leao I.C., Lu Y., Wong J., Chen J.S., Byrne B., August J.T. HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 (LAMP-1) as a DNA plasmid vaccine chimera is highly expressed, traffics to MHC II compartment, and elicits enhanced immune responses. J. Biol. Chem. 278:2003;37926-37936
20. Nakai H., Fuess S., Storm T.A., Meuse L.A., Kay M.A. Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo. Molec. Ther. 7:2003;11221
21. Nakai H., Montini E., Fuess S., Storm T.A., Grompe M., Kay M.A. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34:2003;297-302
22. Nakai H., Montini E., Fuess S., Storm T.A., Meuse L., Finegold M., Grompe M., Kay M.A. Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice. Molec. Ther. 7:2003;101-111
23. Nakai H., Storm T.A., Fuess S., Kay M.A. Pathways of removal of free DNA vector ends in normal and DNA-PKcs-deficient SCID mouse hepatocytes transduced with rAAV vectors. Hum. Gene Ther. 14:2003;871-881
24. Nasioulas G., Zolotukhin A.S., Tabernero C., Solomin L., Cunningham C.P., Pavlakis G.N., Felber B.K. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68:1994;2986-2993
25. Qiu J.T., Song R., Dettenhoffer M., Tian C., August T., Felber B., Pavlakis G.N., Yu X.F. Evaluation of a novel human immunodeficiency virus type 1 gag DNA vaccines for protein expression in mammalian cells and induction of an immune response. J. Virol. 73:1999;9145-9152
26. Reiner S., Zheng S., Corry D., Locksley R. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods. 165:1993;37-46
27. Schneider R., Campbell M., Nasioulas G., Felber B.K., Pavlakis G.N. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 71:1997;4892-4903
28. Song S., Laipis P.J., Berns K.I., Flotte T.R. Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 98:2001;4084-4088
29. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., von Andrian U.H., Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:2003;225-234
30. Xiao X., Li J., Samulski R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:1996;8098-8108
31. Xiao X., Xiao W., Li J., Samulski R.J. A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 71:1997;941-948
32. Xiao W., Chirmule N., Berta S.C., McCullough B., Gao G., Wilson J.M. Gene therapy vectors based on Adeno-associated virus type 1. J. Virol. 73:1999;3994-4003
33. Xin K., Urabe M., Yang J., Nomiyama K., Mizukami H., Hamajima K., Nomiyama H., Saito T., Imai M., Monahan J., Okuda K., Ozawa K., Okuda K. A novel recombinant adeno-associated virus vaccine induces a long-term humoral response to human immunodeficiency virus. Hum. Gene Ther. 12:2001;1047-1061
34. Xin K.Q., Ooki T., Jounai N., Mizukami H., Hamajima K., Kojima Y., Ohba K., Toda Y., Hirai S., Klinman D.M., Ozawa K., Okuda K. A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV. J. Gene Med. 5:2003;438-445
35. Yang J., Zhou W., Zhang Y., Zidon T., Ritchie T., Engelhardt J.F. Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J. Virol. 73:1999;9468-9477
36. Yue Y., Duan D. Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes. Virology. 313:2003;1-7
37. zurMegede J., Chen M.C., Doe B., Schaefer M., Greer C.E., Selby M., Otten G.R., Barnett S.W. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 Gag gene. J. Virol. 74:2000;2628-2635